Literature DB >> 25894644

Increased plasma soluble urokinase plasminogen activator receptor levels in systemic sclerosis: possible association with microvascular abnormalities and extent of fibrosis.

Nóra Legány, Gergely Toldi, Jörg H W Distler, Christian Beyer, Balázs Szalay, László Kovács, Barna Vásárhelyi, Attila Balog.   

Abstract

BACKGROUND: Urokinase plasminogen activator receptor (uPAR) is a key component of the fibrinolytic system involved in extracellular matrix remodeling and angiogenesis. Novel animal models supported the key role of uPAR not only in fibrosis but also in systemic sclerosis (SSc)-related microvascular abnormalities. The aim of this study was to investigate plasma soluble uPAR (suPAR) levels in SSc, and their association with organ-specific involvement.
METHODS: suPAR concentrations were measured by ELISA in SSc patient (n=83) and in healthy controls (n=29). Simultaneously, CRP and ESR were assessed. Detailed clinical data including skin, lung, heart and microvascular characteristics were evaluated at sampling.
RESULTS: suPAR values were higher in SSc patients than in controls. Subgroup analysis showed higher suPAR values in diffuse cutaneous- than in limited cutaneous SSc and correlated with anti-Scl-70+. suPAR levels also associated with pulmonary function test parameters of fibrosis, presence of microvascular lesions (e.g., Raynaud phenomenon, naifold capillaroscopic abnormalities and digital ulcers) and arthritis.
CONCLUSIONS: Our data indicate that suPAR might be a valuable early diagnostic marker of SSc which also correlates with disease severity.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25894644     DOI: 10.1515/cclm-2015-0079

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  8 in total

1.  Comparison of soluble urokinase plasminogen activator receptor, soluble triggering receptor expressed on myeloid cells 1, procalcitonin and C-reactive protein in distinguishing concurrent bacterial infection from idiopathic inflammatory myopathy.

Authors:  Yizhi Xiao; Hui Luo; Bin Zhou; Xiaodan Dai; Jing Huang; Liping Duan; Yunhui You; Weiru Zhang; Hongjun Zhao; Yanli Xie; Yaou Zhou; Wangbin Ning; Tong Li; Sijia Liu; Honglin Zhu; Xiaoyun Xie; Ying Jiang; Shiyao Wu; Weijia He; Yisha Li
Journal:  Rheumatol Int       Date:  2016-11-22       Impact factor: 2.631

2.  Association of Preoperative Basal Inflammatory State, Measured by Plasma suPAR Levels, with Intraoperative Sublingual Microvascular Perfusion in Patients Undergoing Major Non-Cardiac Surgery.

Authors:  Athanasios Chalkias; Nikolaos Papagiannakis; Bernd Saugel; Moritz Flick; Konstantina Kolonia; Zacharoula Angelopoulou; Dimitrios Ragias; Dimitra Papaspyrou; Aikaterini Bouzia; Nicoletta Ntalarizou; Konstantinos Stamoulis; Aikaterini Kyriakaki; Jesper Eugen-Olsen; Eleni Laou; Eleni Arnaoutoglou
Journal:  J Clin Med       Date:  2022-06-10       Impact factor: 4.964

3.  Synergistic effect of human Bone Morphogenic Protein-2 and Mesenchymal Stromal Cells on chronic wounds through hypoxia-inducible factor-1 α induction.

Authors:  Sabine François; Véronique Eder; Karim Belmokhtar; Marie-Christine Machet; Luc Douay; Norbert-Claude Gorin; Marc Benderitter; Alain Chapel
Journal:  Sci Rep       Date:  2017-06-27       Impact factor: 4.379

4.  Association between baseline clinical and imaging findings and the development of digital ulcers in patients with systemic sclerosis.

Authors:  S Friedrich; S Lüders; A M Glimm; S G Werner; G Schmittat; G R Burmester; M Backhaus; G Riemekasten; S Ohrndorf
Journal:  Arthritis Res Ther       Date:  2019-04-15       Impact factor: 5.156

5.  The Clinical Value of Soluble Urokinase Plasminogen Activator Receptor (suPAR) Levels in Autoimmune Connective Tissue Disorders.

Authors:  Barna Vasarhelyi; Gergely Toldi; Attila Balog
Journal:  EJIFCC       Date:  2016-04-20

6.  Integration of Genome-Wide DNA Methylation and Transcription Uncovered Aberrant Methylation-Regulated Genes and Pathways in the Peripheral Blood Mononuclear Cells of Systemic Sclerosis.

Authors:  Honglin Zhu; Chengsong Zhu; Wentao Mi; Tao Chen; Hongjun Zhao; Xiaoxia Zuo; Hui Luo; Quan-Zhen Li
Journal:  Int J Rheumatol       Date:  2018-09-02

Review 7.  The Role of Fibrinolytic Regulators in Vascular Dysfunction of Systemic Sclerosis.

Authors:  Yosuke Kanno
Journal:  Int J Mol Sci       Date:  2019-01-31       Impact factor: 5.923

8.  Association of soluble urokinase plasminogen activator receptor levels with fibrotic and vascular manifestations in systemic sclerosis.

Authors:  Sheraz Butt; Jørgen L Jeppesen; Line Vinderslev Iversen; Mogens Fenger; Jesper Eugen-Olsen; Charlotte Andersson; Søren Jacobsen
Journal:  PLoS One       Date:  2021-02-22       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.